Penumbra (PEN) Stock News
$PEN · NYSE · 1 stories in 30 days$322.50
1D +0.03%1W +0.93%1M +0.05%
BORSA has published 1 story on Penumbra (PEN) in the past 30 days. BORSA’s news read on PEN is bullish at 66/100, based on 1 company event over the past 7 days. PEN last closed at $320.01 on Oct 13, up 0.93% over five sessions and up 0.05% over the past month. Penumbra’s next earnings report is scheduled for Wednesday, Nov 4.
The wire on $PEN
newest first · updated · direct subject stories onlyPenumbra reports positive BOLT-DVT trial results for CAVT in DVT treatment
Penumbra's BOLT-DVT trial shows safety and efficacy of CAVT for DVT, with significant quality-of-life improvements and no device-related deaths or serious adverse events.
bullish 80 · impact 60The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card Penumbra (PEN) stock: common questions
What is the latest Penumbra stock news?
The highest-impact PEN story BORSA published in the past 30 days:
· Penumbra reports positive BOLT-DVT trial results for CAVT in DVT treatment